Modus Therapeutics Holding AB
www.modustx.comModus Therapeutics is a Swedish biotech company developing sevuparin for diseases with high unmet medical need. The Company’s near-term focus is to develop sevuparin for patients with sepsis/septic shock, a severe and often fatal condition.
Read more
Modus Therapeutics is a Swedish biotech company developing sevuparin for diseases with high unmet medical need. The Company’s near-term focus is to develop sevuparin for patients with sepsis/septic shock, a severe and often fatal condition.
Read more
Country
City (Headquarters)
Stockholm
Industry
Employees
1-10
Founded
2011
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Financial Officer
Email ****** @****.comPhone (***) ****-****Chief Financial Officer
Email ****** @****.comPhone (***) ****-****Director Board of Directors
Email ****** @****.comPhone (***) ****-****Other
Email ****** @****.comPhone (***) ****-****
Reach decision makers at Modus Therapeutics Holding AB
Free credits every month!
Modus Therapeutics Holding AB FAQ
Stockholm, Sweden
Biotechnology Research
